Richard Auchus
Endocrinology, Diabetes & Metabolism · Ann Arbor, MINPI 1083670251
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Corcept Therapeutics at 37.4% of the total. 2025 is the largest year on record at $83,063, 6.2 times the $13,317 reported in 2019. Among endocrinology, diabetes & metabolism clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $1045.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$94K
- Neurocrine Biosciences, Inc.$57K
- H. Lundbeck A S$45K
- Recordati_rare_diseases_inc.$21K
- Xeris Pharmaceuticals, Inc.$15K
- Besins Healthcare Ireland Limited$10K
- plus $8K from 5 others
Across 200 payments — averaging $7769.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurocrine Biosciences, Inc.$1.1M
- Recordati_rare_diseases_inc.$253K
- Corcept Therapeutics$183K
- Novartis$43K
- Strongbridge US Inc.$9K
What the payments were for
- Consulting fees$89,49236%
- Speaking & faculty fees$108,45243%
- Travel & lodging$45,69718%
- Food & beverage$5,8602%
- Education$3250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 105 | $93,549 |
| Neurocrine Biosciences, Inc. | 78 | $57,163 |
| H. Lundbeck A S | 17 | $45,277 |
| Recordati_rare_diseases_inc. | 16 | $21,499 |
| Xeris Pharmaceuticals, Inc. | 12 | $14,642 |
| Besins Healthcare Ireland Limited | 4 | $10,163 |
| Novo Nordisk Health Care AG | 3 | $2,520 |
| Blue Earth Diagnostics | 1 | $2,250 |
| Roche Diagnostics International Ltd | 1 | $2,163 |
| Novo Nordisk | 1 | $563 |
| Eton Pharmaceuticals, Inc. | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Korlym$88,282
- CRENESSITY$20,500
- RECORLEV$12,660
- OSILODROSTAT$12,082
- ISTURISA$4,858
- POSLUMA$2,250
- Norditropin$563
How this compares
$249,825 in reported general payments places this provider in the 95th percentile of 219 endocrinology, diabetes & metabolism providers in Michigan.
See all endocrinology, diabetes & metabolism providers in Michigan →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KorlymMifepristone | 24 | $460,832 |
| Hydrocortisone | 15 | $1,164 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Corcept TherapeuticsKorlym | $93,549 | $460,83224 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 219 endocrinology, diabetes & metabolism providers in Michigan.
Other endocrinology, diabetes & metabolism in Ann Arbor
- Elif OralAnn Arbor$81K
- Kenneth FeingoldAnn Arbor$43K
- William HermanAnn Arbor$42K
- Tobias ElseAnn Arbor$31K
- Amy RothbergAnn Arbor$29K
- Joanna Spencer-SegalAnn Arbor$24K
- Gary HammerAnn Arbor$15K
- Arash SoleimanpourAnn Arbor$14K
- Tae Hwa ChunAnn Arbor$7K
- Lowell SchmeltzFarmington Hills$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.